


Overall, there are an estimated one million cases of herpes zoster in the US annually. Furthermore, according to the CDC, the incidence of shingles is approximately four per 1,000 US population annually. Meanwhile, the increasing number of individuals preferring chemotherapy for cancer treatment is fueling cases of chemotherapy-induced pain. There have been growing cases of these disorders, especially in the geriatric population. Market Driver: The presence of a large patient pool related to neuropathic pain is one of the key drivers supporting the pregabalin market growth. Neuropathic pain is associated with various disorders such as diabetic neuropathy, chemotherapy-induced pain, shingles, and herniated disk.
